Copenhagen Malmö Contrast

Copenhagen Malmö Contrast (CMC) is a biotechnology company focused on developing next-generation contrast agents for magnetic resonance imaging (MRI). The company's lead development program is a liver-specific MRI contrast agent designed to improve the detection and characterization of liver lesions, such as hepatocellular carcinoma, by providing superior image quality and safety compared to existing extracellular agents. CMC leverages expertise in chemical synthesis and medical imaging to address unmet needs in diagnostic radiology. Based in the Medicon Valley region, the company aims to enhance precision medicine through better visualization of disease pathology.